Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AEHR TEST SYSTEMS Board/Management Information 2019

Sep 11, 2019

32300_rns_2019-09-11_7eff492b-363b-418c-86c5-12391606c3e1.zip

Board/Management Information

Open in viewer

Opens in your device viewer

8-K/A 1 aehr_8ka.htm AMENDMENT NO.1 Document created using Blueprint(R) - powered by Issuer Direct - www.issuerdirect.com Copyright 2019 Issuer Direct Corporation Blueprint

style header

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

line

FORM 8-K/A

(Amendment No. 1)

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)

July 17, 2019

line

AEHR TEST SYSTEMS

(Exact name of registrant as specified in its charter)

California 000-22893 94-2424084
(State
or other jurisdiction of incorporation) (Commission
File Number) (IRS
Employer Identification
No.)
400 KATO TERRACE, FREMONT, CA 94539
(Address
of principal executive offices, including zip code)
510-623-9400
(Registrant’s
telephone number, including area code)
N/A
(Former
name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

| Title of each class | Trading — Symbol(s) | Name of each exchange on which registered | | --- | --- | --- | | Common Stock | AEHR | The NASDAQ Capital Market |

page break

Explanatory Note

Aehr Test Systems (the “Company”) filed with the Securities and Exchange Commission (the “SEC”) on July 19, 2019 a Current Report on Form 8-K (the “Original Filing”) to disclose that the Company’s board of directors (the “Board”) increased the size of the Board by one director, from six to seven directors, and appointed Laura Oliphant to the Board. At the time of the Original Filing, the Board had not determined to which committees, if any, Ms. Oliphant would be appointed.

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(d) Pursuant to Instruction 2 to Item 5.02 of Form 8-K, the Company is filing this Amendment No. 1 on Form 8-K/A to amend the Original Filing to disclose that, on September 9, 2019, the Board appointed Ms. Oliphant to serve on the Audit Committee of the Board and the Compensation Committee of the Board. Except as stated herein, the Original Filing shall remain in effect.

Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

(a) In addition, the Company clarifies that the increase in the size of the Board by one director, from six to seven directors, was effected by an amendment to Section 3.2 of Article III of the Company’s bylaws (the “Bylaws”) to change the exact number of directors from six to seven. The amendment to the Bylaws was effective as of July 16, 2019. The foregoing description of the amendment to the Bylaws does not purport to be complete and is qualified in its entirety by reference to the Bylaws, which are attached as Exhibit 3.2 to the Company’s Annual Report on Form 10-K for the fiscal year ended May 31, 2019 filed with the SEC on August 28, 2019 and are incorporated herein by reference.

page break

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

| /s/

Kenneth B. Spink
Kenneth
B. Spink
Vice
President of Finance and Chief
Financial Officer

page break